Biology and Genetics of Anti-Müllerian Hormone

  • Nathalie JossoEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 707)


Anti-Müllerian hormone (AMH) also known as Müllerian inhibiting substance (MIS) is a homodimeric glycoprotein selectively involved in reproduction and development. As shown by Cate et al. [1], it belongs to the TGF-β family, with homology essentially to the BMP proteins. Like all members of the family, it is composed of a long N-terminus, which must be cleaved from the short C-terminus for biological activity. The N-terminus is inactive on its own but plays a role in folding and helps the C-terminus cross the cell membrane and get secreted. A 3D putative model of the AMH C-terminus has been constructed by analogy with crystallized membersof the BMP family [2].


Androgen Receptor Inguinal Hernia Granulosa Cell Sertoli Cell Primordial Follicle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., Fisher, R. A., Bertonis, J. M., Torres, G., Wallner, B. P., Ramachandran, K. L., Ragin, R. C., Manganaro, T. F., MacLaughlin, D. T., and Donahoe, P. K. (1986) Cell 45, 685–698PubMedCrossRefGoogle Scholar
  2. 2.
    Belville, C., Van Vlijmen, H., Ehrenfels, C., Pepinsky, R. B., Rezaie, A. R., Picard, J. Y., Josso, N., di Clemente, N., and Cate, R. L. (2004) Mol Endocrinol 18, 708–721PubMedCrossRefGoogle Scholar
  3. 3.
    Belville, C., Maréchal, J. D., Pennetier, S., Carmillo, P., Masgrau, L., Messika-Zeitoun, L., Galey, J., Machado, G., Tréton, D., Gonzalès, J., Picard, J. Y., Josso, N., Cate, R., and di Clemente, N. (2009). Hum Mol Genet 18, 3002–3013PubMedCrossRefGoogle Scholar
  4. 4.
    Josso, N. and di Clemente, N. (2003) Trends Endocrinol Metab 14, 91–97PubMedCrossRefGoogle Scholar
  5. 5.
    Jamin, S. P., Arango, N. A., Mishina, Y., Hanks, M. C., and Behringer, R. R. (2002) Nat Genet 32, 408–410PubMedCrossRefGoogle Scholar
  6. 6.
    Imbeaud, S., Belville, C., Messika-Zeitoun, L., Rey, R., di Clemente, N., Josso, N., and Picard, J. Y. (1996) Hum Mol Genet 5, 1269–1279PubMedCrossRefGoogle Scholar
  7. 7.
    Al-Attar, L., Noël, K., Dutertre, M., Belville, C., Forest, M. G., Burgoyne, P. S., Josso, N., and Rey, R. (1997) J Clin Invest 100, 1335–1343PubMedCrossRefGoogle Scholar
  8. 8.
    Rey, R. A., Belville, C., Nihoul-Fékété, C., et al (1999) J Clin Endocrinol Metab 84, 627–631PubMedCrossRefGoogle Scholar
  9. 9.
    Racine, C., Pask, A. J., Wijayanti, G., di Clemente, N., Picard, J. Y., Shaw, G., Renfree, M. B., and Josso, N. (2009) Sex Dev 3, 317–325PubMedCrossRefGoogle Scholar
  10. 10.
    Vigier, B., Picard, J. Y., Tran, D., Legeai, L., and Josso, N. (1984) Endocrinology 114, 1315–1320PubMedCrossRefGoogle Scholar
  11. 11.
    Visser, J. A. and Themmen, A. P. N. (2005) Mol Cell Endocrinol 234, 81–86PubMedCrossRefGoogle Scholar
  12. 12.
    Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbrok, J. T. J., Grootegoed, J. A., and Themmen, A. P. N. (1999) Endocrinology 140, 5789–5796PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Institut National de la Sante et de la Recherche Medicale (INSERM)ParisFrance

Personalised recommendations